Bioprinted Multi-Cell Type Lung Model for the Study of Viral Inhibitors

Influenza A virus (IAV) continuously causes epidemics and claims numerous lives every year. The available treatment options are insufficient and the limited pertinence of animal models for human IAV infections is hampering the development of new therapeutics. Bioprinted tissue models support studyin...

Full description

Saved in:
Bibliographic Details
Published inViruses Vol. 13; no. 8; p. 1590
Main Authors Berg, Johanna, Weber, Zia, Fechler-Bitteti, Mona, Hocke, Andreas C., Hippenstiel, Stefan, Elomaa, Laura, Weinhart, Marie, Kurreck, Jens
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 11.08.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Influenza A virus (IAV) continuously causes epidemics and claims numerous lives every year. The available treatment options are insufficient and the limited pertinence of animal models for human IAV infections is hampering the development of new therapeutics. Bioprinted tissue models support studying pathogenic mechanisms and pathogen-host interactions in a human micro tissue environment. Here, we describe a human lung model, which consisted of a bioprinted base of primary human lung fibroblasts together with monocytic THP-1 cells, on top of which alveolar epithelial A549 cells were printed. Cells were embedded in a hydrogel consisting of alginate, gelatin and collagen. These constructs were kept in long-term culture for 35 days and their viability, expression of specific cell markers and general rheological parameters were analyzed. When the models were challenged with a combination of the bacterial toxins LPS and ATP, a release of the proinflammatory cytokines IL-1β and IL-8 was observed, confirming that the model can generate an immune response. In virus inhibition assays with the bioprinted lung model, the replication of a seasonal IAV strain was restricted by treatment with an antiviral agent in a dose-dependent manner. The printed lung construct provides an alveolar model to investigate pulmonary pathogenic biology and to support development of new therapeutics not only for IAV, but also for other viruses.
AbstractList Influenza A virus (IAV) continuously causes epidemics and claims numerous lives every year. The available treatment options are insufficient and the limited pertinence of animal models for human IAV infections is hampering the development of new therapeutics. Bioprinted tissue models support studying pathogenic mechanisms and pathogen-host interactions in a human micro tissue environment. Here, we describe a human lung model, which consisted of a bioprinted base of primary human lung fibroblasts together with monocytic THP-1 cells, on top of which alveolar epithelial A549 cells were printed. Cells were embedded in a hydrogel consisting of alginate, gelatin and collagen. These constructs were kept in long-term culture for 35 days and their viability, expression of specific cell markers and general rheological parameters were analyzed. When the models were challenged with a combination of the bacterial toxins LPS and ATP, a release of the proinflammatory cytokines IL-1β and IL-8 was observed, confirming that the model can generate an immune response. In virus inhibition assays with the bioprinted lung model, the replication of a seasonal IAV strain was restricted by treatment with an antiviral agent in a dose-dependent manner. The printed lung construct provides an alveolar model to investigate pulmonary pathogenic biology and to support development of new therapeutics not only for IAV, but also for other viruses.
Influenza A virus (IAV) continuously causes epidemics and claims numerous lives every year. The available treatment options are insufficient and the limited pertinence of animal models for human IAV infections is hampering the development of new therapeutics. Bioprinted tissue models support studying pathogenic mechanisms and pathogen-host interactions in a human micro tissue environment. Here, we describe a human lung model, which consisted of a bioprinted base of primary human lung fibroblasts together with monocytic THP-1 cells, on top of which alveolar epithelial A549 cells were printed. Cells were embedded in a hydrogel consisting of alginate, gelatin and collagen. These constructs were kept in long-term culture for 35 days and their viability, expression of specific cell markers and general rheological parameters were analyzed. When the models were challenged with a combination of the bacterial toxins LPS and ATP, a release of the proinflammatory cytokines IL-1β and IL-8 was observed, confirming that the model can generate an immune response. In virus inhibition assays with the bioprinted lung model, the replication of a seasonal IAV strain was restricted by treatment with an antiviral agent in a dose-dependent manner. The printed lung construct provides an alveolar model to investigate pulmonary pathogenic biology and to support development of new therapeutics not only for IAV, but also for other viruses.Influenza A virus (IAV) continuously causes epidemics and claims numerous lives every year. The available treatment options are insufficient and the limited pertinence of animal models for human IAV infections is hampering the development of new therapeutics. Bioprinted tissue models support studying pathogenic mechanisms and pathogen-host interactions in a human micro tissue environment. Here, we describe a human lung model, which consisted of a bioprinted base of primary human lung fibroblasts together with monocytic THP-1 cells, on top of which alveolar epithelial A549 cells were printed. Cells were embedded in a hydrogel consisting of alginate, gelatin and collagen. These constructs were kept in long-term culture for 35 days and their viability, expression of specific cell markers and general rheological parameters were analyzed. When the models were challenged with a combination of the bacterial toxins LPS and ATP, a release of the proinflammatory cytokines IL-1β and IL-8 was observed, confirming that the model can generate an immune response. In virus inhibition assays with the bioprinted lung model, the replication of a seasonal IAV strain was restricted by treatment with an antiviral agent in a dose-dependent manner. The printed lung construct provides an alveolar model to investigate pulmonary pathogenic biology and to support development of new therapeutics not only for IAV, but also for other viruses.
Author Weinhart, Marie
Fechler-Bitteti, Mona
Hocke, Andreas C.
Hippenstiel, Stefan
Elomaa, Laura
Berg, Johanna
Kurreck, Jens
Weber, Zia
AuthorAffiliation 2 Department of Internal Medicine/Infectious and Respiratory Diseases, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115 Berlin, Germany; andreas.hocke@charite.de (A.C.H.); stefan.hippenstiel@charite.de (S.H.)
3 Department of Organic Chemistry, Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany; laura.elomaa@fu-berlin.de (L.E.); marie.weinhart@fu-berlin.de (M.W.)
1 Department of Applied Biochemistry, Technische Universität Berlin, Chair of Applied Biochemistry, 10623 Berlin, Germany; z.weber@tu-berlin.de (Z.W.); m.fechlerbitteti@tu-berlin.de (M.F.-B.); jens.kurreck@tu-berlin.de (J.K.)
AuthorAffiliation_xml – name: 1 Department of Applied Biochemistry, Technische Universität Berlin, Chair of Applied Biochemistry, 10623 Berlin, Germany; z.weber@tu-berlin.de (Z.W.); m.fechlerbitteti@tu-berlin.de (M.F.-B.); jens.kurreck@tu-berlin.de (J.K.)
– name: 3 Department of Organic Chemistry, Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany; laura.elomaa@fu-berlin.de (L.E.); marie.weinhart@fu-berlin.de (M.W.)
– name: 2 Department of Internal Medicine/Infectious and Respiratory Diseases, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115 Berlin, Germany; andreas.hocke@charite.de (A.C.H.); stefan.hippenstiel@charite.de (S.H.)
Author_xml – sequence: 1
  givenname: Johanna
  surname: Berg
  fullname: Berg, Johanna
– sequence: 2
  givenname: Zia
  surname: Weber
  fullname: Weber, Zia
– sequence: 3
  givenname: Mona
  surname: Fechler-Bitteti
  fullname: Fechler-Bitteti, Mona
– sequence: 4
  givenname: Andreas C.
  surname: Hocke
  fullname: Hocke, Andreas C.
– sequence: 5
  givenname: Stefan
  surname: Hippenstiel
  fullname: Hippenstiel, Stefan
– sequence: 6
  givenname: Laura
  surname: Elomaa
  fullname: Elomaa, Laura
– sequence: 7
  givenname: Marie
  orcidid: 0000-0002-5116-5054
  surname: Weinhart
  fullname: Weinhart, Marie
– sequence: 8
  givenname: Jens
  orcidid: 0000-0002-1469-0052
  surname: Kurreck
  fullname: Kurreck, Jens
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34452455$$D View this record in MEDLINE/PubMed
BookMark eNqFkktvEzEURi1URB-w4A8gS2xgMdQevzdIJYISKRULClvLHtuJo4kdPJ5K-fdMSInaComVLfv46LvX9xycpJw8AK8x-kCIQpd3mCCJmULPwBlWSjVUYXbyYH8KzodhjRDnCokX4JRQylrK2Bm4_hTztsRUvYM3Y19jM_N9D293Ww8XY1rCm-x8D0MusK48_F5Ht4M5wJ-xmB7O0yraWHMZXoLnwfSDf3W_XoAfXz7fzr42i2_X89nVoukYl7VxLaGWS-UI985w7jhnjBNpBcGe2SAdDsarDiGGCcPUdVggQYVnRjhHCbkA84PXZbPWU_KNKTudTdR_DnJZalNq7HqvrXRWWCuJoJi2QtmAMFIsYIEREkFNro8H13a0G-86n-pU1CPp45sUV3qZ77SkqBWUT4J394KSf41-qHoTh27qn0k-j4NuOeGCSyHk_1HGOaKYUzqhb5-g6zyWNHV1TzGBOVL7Rrx5GP6Y-u_XTsD7A9CVPAzFhyOCkd6PjT6OzcRePmG7WE2NeV937P_x4jep2sB7
CitedBy_id crossref_primary_10_1183_13993003_00417_2022
crossref_primary_10_3390_bioengineering11090862
crossref_primary_10_1021_acsabm_4c00579
crossref_primary_10_3390_jfb15010020
crossref_primary_10_1016_j_bioactmat_2023_06_006
crossref_primary_10_1016_j_lfs_2023_122208
crossref_primary_10_1088_1758_5090_ad91e2
crossref_primary_10_3390_ijms251910268
crossref_primary_10_3390_v13102030
crossref_primary_10_1016_j_ijpharm_2023_123313
crossref_primary_10_1016_j_bioadv_2022_213103
crossref_primary_10_1039_D2BM00797E
crossref_primary_10_1016_j_bprint_2024_e00342
crossref_primary_10_1088_1758_5090_aca8cf
crossref_primary_10_3390_ijms24076071
crossref_primary_10_1016_j_bioactmat_2024_09_025
crossref_primary_10_3389_fphar_2023_1130074
crossref_primary_10_3390_ijms24076232
crossref_primary_10_1115_1_4065214
crossref_primary_10_1097_MD_0000000000032589
crossref_primary_10_1016_j_bioactmat_2022_04_008
crossref_primary_10_1088_1758_5090_aced23
crossref_primary_10_1016_j_bprint_2022_e00255
crossref_primary_10_3390_futurepharmacol3010004
crossref_primary_10_3390_gels10010008
crossref_primary_10_1080_17452759_2024_2384662
Cites_doi 10.1371/journal.pone.0137108
10.3389/fimmu.2020.01722
10.1183/09031936.00186214
10.1007/s00441-002-0653-5
10.1038/cmi.2015.74
10.1371/journal.pone.0164438
10.1007/s10439-016-1640-4
10.1021/acs.chemrev.9b00789
10.3390/cells8080830
10.1165/rcmb.2007-0328OC
10.1183/13993003.01953-2016
10.1128/MMBR.05015-11
10.1038/ncomms4935
10.1002/path.4808
10.1007/s00441-016-2546-z
10.1128/JVI.79.23.14933-14944.2005
10.1016/j.virol.2015.02.030
10.1038/s41598-019-38565-z
10.1039/C7BM00765E
10.4049/jimmunol.1402283
10.4049/jimmunol.0901363
10.1002/biot.201700341
10.1016/j.coi.2010.06.003
10.1111/febs.14582
10.1038/nrmicro1871
10.1021/acs.molpharmaceut.8b00531
10.4049/jimmunol.172.5.2731
10.1146/annurev.me.35.020184.000405
10.1111/irv.12317
10.1038/s41598-018-31880-x
10.3390/v20801530
10.1086/649785
10.1016/j.phrs.2018.11.002
10.1152/physiol.00036.2016
10.1016/j.tiv.2014.09.014
10.1007/s00408-016-9875-2
10.1007/s12263-008-0107-0
10.3390/v12121425
10.3390/v12111298
10.1016/S1473-3099(17)30396-1
10.1038/srep40360
10.1088/1758-5090/ab5158
10.3390/v12111294
10.1128/JVI.01619-09
10.4049/jimmunol.182.3.1296
10.1172/JCI62139
10.1016/j.biotechadv.2015.12.011
10.1038/507423a
10.2147/IDR.S58551
10.1016/j.coviro.2015.06.009
10.1093/infdis/jis455
10.1186/rr199
10.1038/srep24474
10.1038/s41551-019-0471-7
10.3390/ijms19103129
10.1371/journal.ppat.1000661
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOA
DOI 10.3390/v13081590
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE

Publicly Available Content Database
AGRICOLA

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1999-4915
ExternalDocumentID oai_doaj_org_article_b8db7bb837414279bf01095f171007f9
PMC8402746
34452455
10_3390_v13081590
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom--UK
United States--US
Germany
GeographicLocations_xml – name: United Kingdom--UK
– name: United States--US
– name: Germany
GroupedDBID ---
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACUHS
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E3Z
EBD
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
TR2
TUS
UKHRP
3V.
CGR
CUY
CVF
ECM
EIF
ISR
NPM
7U9
7XB
8FK
AZQEC
COVID
DWQXO
GNUQQ
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c568t-d234b689d36eda66d6655638b731e5bf8d1fae9c00513514dc170747e5a7dd433
IEDL.DBID M48
ISSN 1999-4915
IngestDate Wed Aug 27 01:25:15 EDT 2025
Thu Aug 21 18:34:45 EDT 2025
Fri Jul 11 02:43:19 EDT 2025
Fri Jul 11 00:25:40 EDT 2025
Fri Jul 25 12:06:40 EDT 2025
Wed Feb 19 02:26:58 EST 2025
Tue Jul 01 02:48:26 EDT 2025
Thu Apr 24 23:06:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords human lung model
LPS stimulation
bioprinting
influenza A virus
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c568t-d234b689d36eda66d6655638b731e5bf8d1fae9c00513514dc170747e5a7dd433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1469-0052
0000-0002-5116-5054
OpenAccessLink https://www.proquest.com/docview/2565716093?pq-origsite=%requestingapplication%
PMID 34452455
PQID 2565716093
PQPubID 2032319
ParticipantIDs doaj_primary_oai_doaj_org_article_b8db7bb837414279bf01095f171007f9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8402746
proquest_miscellaneous_2636768778
proquest_miscellaneous_2566041644
proquest_journals_2565716093
pubmed_primary_34452455
crossref_primary_10_3390_v13081590
crossref_citationtrail_10_3390_v13081590
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210811
PublicationDateYYYYMMDD 2021-08-11
PublicationDate_xml – month: 8
  year: 2021
  text: 20210811
  day: 11
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Viruses
PublicationTitleAlternate Viruses
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_50
Wang (ref_57) 2009; 182
Xu (ref_17) 2008; 39
Weinheimer (ref_10) 2012; 206
Herold (ref_11) 2015; 45
Baker (ref_32) 2012; 125
Mandrycky (ref_37) 2016; 34
Fuchs (ref_56) 2003; 311
ref_55
Berg (ref_39) 2018; 8
ref_52
Mazzoleni (ref_24) 2009; 4
Bienenstock (ref_1) 1984; 35
ref_15
Peiris (ref_7) 2010; 22
Murphy (ref_38) 2020; 4
Burgess (ref_53) 2016; 240
Liu (ref_59) 2018; 15
Mestas (ref_27) 2004; 172
Unkel (ref_9) 2012; 122
Bhowmick (ref_31) 2016; 194
Cheng (ref_2) 2015; 9
Nicholas (ref_30) 2015; 194
Gretebeck (ref_25) 2015; 13
Osterlund (ref_4) 2010; 84
Woo (ref_5) 2010; 201
Zscheppang (ref_22) 2018; 13
Tumpey (ref_18) 2005; 79
Perrin (ref_20) 2014; 507
Berg (ref_29) 2017; 50
Kumar (ref_58) 2017; 7
Weinhart (ref_51) 2019; 139
Inci (ref_36) 2018; 6
Sun (ref_49) 2020; 12
Mota (ref_48) 2020; 120
ref_35
Berg (ref_40) 2021; 38
Liu (ref_16) 2018; 17
Hasan (ref_54) 2018; 285
Sutton (ref_26) 2015; 479–480
Hocke (ref_12) 2017; 367
Bauernfeind (ref_46) 2009; 183
Tisoncik (ref_8) 2012; 76
Bonnier (ref_33) 2015; 29
Troeger (ref_3) 2017; 17
Radigan (ref_21) 2015; 8
Duval (ref_34) 2017; 32
Wu (ref_45) 2016; 6
Vanderburgh (ref_28) 2017; 45
ref_47
Park (ref_43) 2019; 9
ref_42
ref_41
Pati (ref_44) 2014; 5
Liu (ref_6) 2016; 13
Irvin (ref_19) 2003; 4
Bouvier (ref_23) 2010; 2
Kadioglu (ref_14) 2008; 6
Kumar (ref_13) 2020; 11
References_xml – ident: ref_15
  doi: 10.1371/journal.pone.0137108
– volume: 11
  start-page: 1722
  year: 2020
  ident: ref_13
  article-title: Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.01722
– volume: 45
  start-page: 1463
  year: 2015
  ident: ref_11
  article-title: Influenza virus-induced lung injury: Pathogenesis and implications for treatment
  publication-title: Eur. Respir. J.
  doi: 10.1183/09031936.00186214
– volume: 311
  start-page: 31
  year: 2003
  ident: ref_56
  article-title: Differentiation of human alveolar epithelial cells in primary culture: Morphological characterization and synthesis of caveolin-1 and surfactant protein-C
  publication-title: Cell Tissue Res.
  doi: 10.1007/s00441-002-0653-5
– volume: 13
  start-page: 3
  year: 2016
  ident: ref_6
  article-title: The cytokine storm of severe influenza and development of immunomodulatory therapy
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/cmi.2015.74
– ident: ref_55
  doi: 10.1371/journal.pone.0164438
– volume: 45
  start-page: 164
  year: 2017
  ident: ref_28
  article-title: 3D Printing of Tissue Engineered Constructs for In Vitro Modeling of Disease Progression and Drug Screening
  publication-title: Ann. Biomed. Eng.
  doi: 10.1007/s10439-016-1640-4
– volume: 38
  start-page: 269
  year: 2021
  ident: ref_40
  article-title: Clean Bioprinting—Fabrication of 3D Organ Models Devoid of Animal Components
  publication-title: Altex Altern. Anim. Exp.
– volume: 120
  start-page: 10547
  year: 2020
  ident: ref_48
  article-title: Bioprinting: From Tissue and Organ Development to in Vitro Models
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.9b00789
– ident: ref_42
  doi: 10.3390/cells8080830
– volume: 125
  start-page: 3015
  year: 2012
  ident: ref_32
  article-title: Deconstructing the third dimension—How 3D culture microenvironments alter cellular cues
  publication-title: J. Cell Sci.
– volume: 39
  start-page: 522
  year: 2008
  ident: ref_17
  article-title: Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.2007-0328OC
– volume: 50
  start-page: 1601953
  year: 2017
  ident: ref_29
  article-title: Tyk2 as a target for immune regulation in human viral/bacterial pneumonia
  publication-title: Eur. Respir. J.
  doi: 10.1183/13993003.01953-2016
– volume: 76
  start-page: 16
  year: 2012
  ident: ref_8
  article-title: Into the Eye of the Cytokine Storm
  publication-title: Microbiol. Mol. Biol. Rev.
  doi: 10.1128/MMBR.05015-11
– volume: 5
  start-page: 3935
  year: 2014
  ident: ref_44
  article-title: Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms4935
– volume: 240
  start-page: 397
  year: 2016
  ident: ref_53
  article-title: The extracellular matrix—The under-recognized element in lung disease?
  publication-title: J. Pathol.
  doi: 10.1002/path.4808
– volume: 367
  start-page: 511
  year: 2017
  ident: ref_12
  article-title: Human lung ex vivo infection models
  publication-title: Cell Tissue Res.
  doi: 10.1007/s00441-016-2546-z
– volume: 79
  start-page: 14933
  year: 2005
  ident: ref_18
  article-title: Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.23.14933-14944.2005
– volume: 479–480
  start-page: 247
  year: 2015
  ident: ref_26
  article-title: Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
  publication-title: Virology
  doi: 10.1016/j.virol.2015.02.030
– volume: 9
  start-page: 2103
  year: 2019
  ident: ref_43
  article-title: Experimental Tracheal Replacement Using 3-dimensional Bioprinted Artificial Trachea with Autologous Epithelial Cells and Chondrocytes
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-38565-z
– volume: 6
  start-page: 915
  year: 2018
  ident: ref_36
  article-title: Bioinks for 3D bioprinting: An overview
  publication-title: Biomater. Sci.
  doi: 10.1039/C7BM00765E
– volume: 194
  start-page: 6144
  year: 2015
  ident: ref_30
  article-title: A novel lung explant model for the ex vivo study of efficacy and mechanisms of anti-influenza drugs
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1402283
– volume: 183
  start-page: 787
  year: 2009
  ident: ref_46
  article-title: Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0901363
– volume: 13
  start-page: 1700341
  year: 2018
  ident: ref_22
  article-title: Human Pulmonary 3D Models For Translational Research
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.201700341
– volume: 22
  start-page: 475
  year: 2010
  ident: ref_7
  article-title: Host response to influenza virus: Protection versus immunopathology
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2010.06.003
– volume: 285
  start-page: 4343
  year: 2018
  ident: ref_54
  article-title: A guide to polarized airway epithelial models for studies of host-pathogen interactions
  publication-title: FEBS J.
  doi: 10.1111/febs.14582
– volume: 6
  start-page: 288
  year: 2008
  ident: ref_14
  article-title: The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro1871
– volume: 15
  start-page: 4110
  year: 2018
  ident: ref_59
  article-title: A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a “PB2 Inhibitor”
  publication-title: Mol. Pharm.
  doi: 10.1021/acs.molpharmaceut.8b00531
– volume: 172
  start-page: 2731
  year: 2004
  ident: ref_27
  article-title: Of mice and not men: Differences between mouse and human immunology
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.5.2731
– volume: 17
  start-page: 5484
  year: 2018
  ident: ref_16
  article-title: LPSinduced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NFkappaB, STAT3 or AP1 activation
  publication-title: Mol. Med. Rep.
– volume: 35
  start-page: 49
  year: 1984
  ident: ref_1
  article-title: The lung as an immunologic organ
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev.me.35.020184.000405
– volume: 9
  start-page: 13
  year: 2015
  ident: ref_2
  article-title: Burden of influenza-associated deaths in the Americas, 2002–2008
  publication-title: Influenza Other Resp.
  doi: 10.1111/irv.12317
– volume: 8
  start-page: 13877
  year: 2018
  ident: ref_39
  article-title: Optimization of cell-laden bioinks for 3D bioprinting and efficient infection with influenza A virus
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-31880-x
– volume: 2
  start-page: 1530
  year: 2010
  ident: ref_23
  article-title: Animal Models for Influenza Virus Pathogenesis and Transmission
  publication-title: Viruses
  doi: 10.3390/v20801530
– volume: 201
  start-page: 346
  year: 2010
  ident: ref_5
  article-title: Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies
  publication-title: J. Infect. Dis.
  doi: 10.1086/649785
– volume: 139
  start-page: 446
  year: 2019
  ident: ref_51
  article-title: 3D organ models-Revolution in pharmacological research?
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2018.11.002
– volume: 32
  start-page: 266
  year: 2017
  ident: ref_34
  article-title: Modeling Physiological Events in 2D vs. 3D Cell Culture
  publication-title: Physiology
  doi: 10.1152/physiol.00036.2016
– volume: 29
  start-page: 124
  year: 2015
  ident: ref_33
  article-title: Cell viability assessment using the Alamar blue assay: A comparison of 2D and 3D cell culture models
  publication-title: Toxicol. Vitr.
  doi: 10.1016/j.tiv.2014.09.014
– volume: 194
  start-page: 419
  year: 2016
  ident: ref_31
  article-title: Cells and Culture Systems Used to Model the Small Airway Epithelium
  publication-title: Lung
  doi: 10.1007/s00408-016-9875-2
– volume: 4
  start-page: 13
  year: 2009
  ident: ref_24
  article-title: Modelling tissues in 3D: The next future of pharmaco-toxicology and food research?
  publication-title: Genes Nutr.
  doi: 10.1007/s12263-008-0107-0
– ident: ref_50
  doi: 10.3390/v12121425
– ident: ref_52
  doi: 10.3390/v12111298
– volume: 17
  start-page: 1133
  year: 2017
  ident: ref_3
  article-title: Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: A systematic analysis for the Global Burden of Disease Study 2015
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(17)30396-1
– volume: 7
  start-page: 40360
  year: 2017
  ident: ref_58
  article-title: Influenza virus exploits tunneling nanotubes for cell-to-cell spread
  publication-title: Sci. Rep.
  doi: 10.1038/srep40360
– volume: 12
  start-page: 022002
  year: 2020
  ident: ref_49
  article-title: The bioprinting roadmap
  publication-title: Biofabrication
  doi: 10.1088/1758-5090/ab5158
– ident: ref_35
  doi: 10.3390/v12111294
– volume: 84
  start-page: 1414
  year: 2010
  ident: ref_4
  article-title: Pandemic H1N1 2009 Influenza A Virus Induces Weak Cytokine Responses in Human Macrophages and Dendritic Cells and Is Highly Sensitive to the Antiviral Actions of Interferons
  publication-title: J. Virol.
  doi: 10.1128/JVI.01619-09
– volume: 182
  start-page: 1296
  year: 2009
  ident: ref_57
  article-title: Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.182.3.1296
– volume: 122
  start-page: 3652
  year: 2012
  ident: ref_9
  article-title: Alveolar epithelial cells orchestrate DC function in murine viral pneumonia
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI62139
– volume: 34
  start-page: 422
  year: 2016
  ident: ref_37
  article-title: 3D bioprinting for engineering complex tissues
  publication-title: Biotechnol. Adv.
  doi: 10.1016/j.biotechadv.2015.12.011
– volume: 507
  start-page: 423
  year: 2014
  ident: ref_20
  article-title: Make mouse studies work
  publication-title: Nature
  doi: 10.1038/507423a
– volume: 8
  start-page: 311
  year: 2015
  ident: ref_21
  article-title: Modeling human influenza infection in the laboratory
  publication-title: Infect. Drug Resist.
  doi: 10.2147/IDR.S58551
– volume: 13
  start-page: 123
  year: 2015
  ident: ref_25
  article-title: Animal models for SARS and MERS coronaviruses
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2015.06.009
– volume: 206
  start-page: 1685
  year: 2012
  ident: ref_10
  article-title: Influenza A Viruses Target Type II Pneumocytes in the Human Lung
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jis455
– volume: 4
  start-page: 4
  year: 2003
  ident: ref_19
  article-title: Measuring the lung function in the mouse: The challenge of size
  publication-title: Respir. Res.
  doi: 10.1186/rr199
– volume: 6
  start-page: 24474
  year: 2016
  ident: ref_45
  article-title: Bioprinting three-dimensional cell-laden tissue constructs with controllable degradation
  publication-title: Sci. Rep.
  doi: 10.1038/srep24474
– volume: 4
  start-page: 370
  year: 2020
  ident: ref_38
  article-title: Opportunities and challenges of translational 3D bioprinting
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-019-0471-7
– ident: ref_41
  doi: 10.3390/ijms19103129
– ident: ref_47
  doi: 10.1371/journal.ppat.1000661
SSID ssj0066907
Score 2.4140866
Snippet Influenza A virus (IAV) continuously causes epidemics and claims numerous lives every year. The available treatment options are insufficient and the limited...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1590
SubjectTerms A549 Cells
alginates
Alginic acid
Alveoli
Animal models
antiviral agents
Antiviral Agents - pharmacology
Antiviral drugs
Bioprinting
Cell culture
Collagen
dose response
Drug development
epithelium
Fibroblasts
Gelatin
Glucose
Host-Pathogen Interactions - drug effects
human lung model
Humans
Hydrogels
IL-1β
Immune response
In Vitro Techniques - methods
Infections
Inflammation
Influenza
Influenza A
Influenza A virus
Influenza A virus - drug effects
Influenza A virus - pathogenicity
Interleukin 8
Lipopolysaccharides
LPS stimulation
Lung - cytology
Lung - drug effects
Lung - virology
Lungs
Monocytes
Physiology
Shear strain
therapeutics
THP-1 Cells
viability
Viral infections
Virus Replication - drug effects
Viruses
Viscoelasticity
Viscosity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS91AEB-KIHgpam2NVVmLh16C2exnjq1orbSeavEWsl_44JEn-l7B_96ZJC_4ithLbyE7kN3ZnZ35ZWd_A3BsnCKS8yavJHc5rhCfO5dEbirNE_rj5Eu6O_zzSl9cy8sbdfOs1BflhPX0wL3iTpwNzjiHOEpyWZrKJTrMUYkTLY1J3dU99HlLMNXvwZowX88jJBDUn_zBndqi4y5WvE9H0v9SZPl3guQzj3O-CW-HUJF96bu4BW9iuw3rffHIx3fwDZ_orxyGjKy7RpufxumUEbBkP9CEGZU5mzIMShkGeYwSBh_ZLLHfE_wW-97eTtyESu3swPX52a_Ti3woi5B7pe08D6WQTtsqCB1Do3XQmli-rDOCR-WSDTw1sfJkb5SnHzw3RJMfVWNCkEK8h7V21sZdYKXXEVWJMVDhZYPWGERTFcFY3qTKa5PB56W6aj9whlPpimmN2IE0W4-azeDTKHrXE2W8JPSVdD4KELd19wJnvB5mvP7XjGewv5yxejC4h7qk41uui0pkcDQ2o6nQ-UfTxtmik9EFBqBSviKjicLOGmMz-NAvgrG3QkpVSqUyMCvLY2U4qy3t5Laj7EYYjfBf7_2P8X-EjZISa4iXl-_D2vx-EQ8wMpq7w84IngBkjAlA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RIqReEK-WQEEGceBideN3TggqSkHAiaK9RfGrXWmVlHaL1H_PTJINLKp6i-KR4oxn7Pns8TcAb6zXRHLe8EqVnqOFBO59ltxWpsy4Hucg6O7wt-_m-ER9mev5uOF2OaZVrufEfqKOXaA98gNB53OlQQD-7vwXp6pRdLo6ltDYgrtEXUYpXXY-AS5DyG9gE5II7Q9-43ztcPmebaxBPVX_TfHl_2mS_6w7Rw_g_hgwsvfDCD-EO6l9BPeGEpLXj-ETPtHeHAaOrL9Myw_TcskIXrKv6MiMip0tGYamDEM9RmmD16zL7OcCv8U-t2cLv6CCO0_g5Ojjj8NjPhZH4EEbt-JRSOWNq6I0KTbGRGOI68t5K8ukfXaxzE2qAnkdZevHUFoiy0-6sTEqKXdhu-3a9BSYCCbpjEBOzIJq0CejbKpZtK5schWMLeDtWl11GJnDqYDFskYEQZqtJ80W8HoSPR_oMm4S-kA6nwSI4bp_0V2c1qPD1N5Fb71H_KxKJWzlMx3iYTeJjsjmqoD99YjVo9td1n-NpIBXUzM6DJ2CNG3qrnoZM8MwVKlbZAwR2TlrXQF7gxFMvZVKaaG0LsBumMfG72y2tIuznrgbwbSwyjy7vevPYUdQ4gzx7pb7sL26uEovMPJZ-Ze9ef8B5CkByw
  priority: 102
  providerName: ProQuest
Title Bioprinted Multi-Cell Type Lung Model for the Study of Viral Inhibitors
URI https://www.ncbi.nlm.nih.gov/pubmed/34452455
https://www.proquest.com/docview/2565716093
https://www.proquest.com/docview/2566041644
https://www.proquest.com/docview/2636768778
https://pubmed.ncbi.nlm.nih.gov/PMC8402746
https://doaj.org/article/b8db7bb837414279bf01095f171007f9
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB9qi-CL-G3aeqzigy_R22Q_sg8itvRDsUXEk3sL2eyuPQg5e71K77_vTJILRg7xJYTshGwmO5n57ez-BuC1tpJIzovYCG5jHCFlbG1IY20UD-iPQ5nQ3uGzc3U6EZ-ncroF6xqbnQKvNkI7qic1WVRvby5XH9Dg3xPiRMj-7jf-hzN0y4jcd9AhabLPM9EnExQBwCa5bKigGpctwdDw1oFbatj7N4Wcf6-c_MMVHT-A-10MyT62H_0hbPn6Edxtq0quHsMJntF0HcaSrNlfGx_6qmKEONkXtG1G9c8qhtEqw-iP0UrCFZsH9mOGz2Kf6ouZnVENnicwOT76fngad_US4lKqbBm7JBVWZcalyrtCKacU0X9lVqfcSxsyx0PhTUmGSAv4Xck18ed7WWjnRJo-he16XvvnwJJSeRkQ2yXjUhRopi4tzNjpjBfBlEpH8GatrrzsyMSppkWVI6ggzea9ZiN41Yv-ahk0NgkdkM57ASK9bi7MFz_zzoZymzmrrUVILbhItLGB8nrYTWIo0sFEsL_-Yvl6IOUJ5XW5Gps0gpd9M9oQJUaK2s-vGxk1xshUiH_IKOK2y7TOInjWDoK-t6kQMhFSRqAHw2PwOsOWenbRcHkjvk60ULv_0bc9uJfQghri4-X7sL1cXPsXGBEt7Qju6Kkewc7B0fnXb6NmXgGPJ1M-aizhFuMmC4c
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWyG4IN4EChgEEpeoiePYyQEhWlp26XaFUIt6S-MXXWmVlHYL2j_Fb2Qmj4VFVW-9RfFIccbj8Xz2-BuA10qnRHJehrmIdYgWYkKtfRKqXMYe12NvON0d3p_I4aH4fJQercHv_i4MpVX2PrFx1LY2tEe-yel8LpYIwN-f_gipahSdrvYlNFqz2HOLXwjZzt-NPuL4vuF8d-dgexh2VQVCk8psHlqeCC2z3CbS2VJKKyWRZGVaJbFLtc9s7EuXGzJXSnO3JlbEMu_SUlkraAMUXf66SBDKDGB9a2fy5Wvv-yVhzZa_KEnyaPMnrhAZBgzRyqrXFAe4LKL9PzHzn5Vu9w7c7kJU9qG1qbuw5qp7cKMtWrm4D5_wiXYDMVRlzfXdcNvNZowALRuj62BUXm3GMBhmGFwySlRcsNqzb1P8FhtVJ1M9pRI_D-DwWhT3EAZVXbnHwLiRLvUIHXlkRIlewCZlHlmVxaXPjVQBvO3VVZiOq5xKZswKxCyk2WKp2QBeLUVPW4KOy4S2SOdLAeLUbl7UZ9-LbooWOrNaaY2IXcSCq1x7OjbEbhIBkvJ5ABv9iBXdRD8v_pplAC-XzThF6dylrFx90cjICANfIa6QkUSdlymVBfCoNYJlbxMhUi7SNAC1Yh4rv7PaUk1PGqpwhO9cCfnk6q6_gJvDg_1xMR5N9p7CLU5pO8T6G2_AYH524Z5h3DXXzztjZ3B83fPrDya9Py4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRSAuFW8CBQwCiUu0iePYyQEhaFm6tFQcKNpbiF_tSquktFvQ_rX-us7kBYuq3nqL1iOtM5kZz2ePvwF4rXRKJOdlmItYh2ghJtTaJ6HKZexxPfaG093hr_ty50B8mabTNTjv78JQWWUfE5tAbWtDe-QjTudzsUQAPvJdWcS37fH7418hdZCik9a-nUZrIrtu-Qfh2-m7yTZ-6zecjz9939oJuw4DoUlltggtT4SWWW4T6WwppZWSCLMyrZLYpdpnNvalyw2ZLpW8WxMrYpx3aamsFbQZiuH_hsIx8jE1HcCeJNTZMhklSR6NfuNakWHqEK2sf02bgMty2_9LNP9Z88Z3YKNLVtmH1rruwpqr7sHNtn3l8j58xifaF8SklTUXecMtN58zgrZsD4MIo0Zrc4ZpMcM0k1HJ4pLVnv2Y4X-xSXU00zNq9vMADq5FbQ9hvaor9xgYN9KlHkEkj4woMR7YpMwjq7K49LmRKoC3vboK07GWU_OMeYHohTRbDJoN4NUgetxSdVwm9JF0PggQu3bzQ31yWHTOWujMaqU1YncRC65y7ekAEadJVEjK5wFs9l-s6Fz-tPhroAG8HIbRWekEpqxcfdbIyAhTYCGukJFEopcplQXwqDWCYbaJECkXaRqAWjGPlddZHalmRw1pOAJ5roR8cvXUX8At9Kpib7K_-xRuc6rfIfrfeBPWFydn7hkmYAv9vLF0Bj-v27UuAIaqQf4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bioprinted+Multi-Cell+Type+Lung+Model+for+the+Study+of+Viral+Inhibitors&rft.jtitle=Viruses&rft.au=Berg%2C+Johanna&rft.au=Weber%2C+Zia&rft.au=Fechler-Bitteti%2C+Mona&rft.au=Hocke%2C+Andreas+C&rft.date=2021-08-11&rft.issn=1999-4915&rft.eissn=1999-4915&rft.volume=13&rft.issue=8&rft_id=info:doi/10.3390%2Fv13081590&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon